What Sorrento Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ji Henry | See Remarks | Mar 17 | In/At-money Exercise · X | +19,500 | $0.80 | +$15.7K | 20,000 |
| Ji Henry | See Remarks | Dec 21 | In/At-money Exercise · X | +300 | $5.50 | +$1.65K | 500 |
| Ji Henry | See Remarks | Dec 15 | Grant / award · A | +1,500,000 | — | — | 6,265,805 |
| Ji Henry | See Remarks | Dec 02 | In/At-money Exercise · X | +200 | $5.50 | +$1.1K | 200 |
| Ji Henry | See Remarks | Sep 07 | Open-market buy · P | +88,888 | $2.02 | +$179K | 4,765,805 |
| Ji Henry | See Remarks | Sep 06 | Open-market buy · P | +55,555 | $1.96 | +$109K | 4,676,917 |
| Ji Henry | See Remarks | Sep 02 | Grant / award · A | +2,500,000 | — | — | 4,621,362 |
| Ji Henry | See Remarks | Aug 26 | Open-market buy · P | +33,333 | $2.11 | +$70.3K | 2,121,362 |
| Ji Henry | See Remarks | Aug 25 | Open-market buy · P | +22,222 | $2.06 | +$45.8K | 2,088,029 |
| Ji Henry | See Remarks | Jun 14 | Open-market buy · P | +10,000 | $1.40 | +$14K | 2,065,807 |
| Janda Kim | Director | Dec 27 | Open-market sale · S | −3,000 | $5.88 | −$17.6K | 3,000 |
| Janda Kim | Director | Dec 27 | Exercise / conversion · M | +3,000 | $4.00 | +$12K | 6,000 |
| Ji Henry | See Remarks | Sep 29 | Exercise / conversion · M | +10,000 | $4.00 | +$40K | 2,055,807 |
| Janda Kim | Director | Sep 27 | Open-market sale · S | −42,357 | $8.02 | −$340K | 3,000 |
| Janda Kim | Director | Sep 27 | Exercise / conversion · M | +35,000 | $1.80 | +$63K | 38,000 |
| Janda Kim | Director | Sep 27 | Exercise / conversion · M | +7,357 | $3.57 | +$26.3K | 45,357 |
| Janda Kim | Director | Sep 13 | Open-market sale · S | −8,000 | $8.04 | −$64.3K | 3,000 |
| Janda Kim | Director | Sep 13 | Exercise / conversion · M | +8,000 | $3.50 | +$28K | 11,000 |
| Smith Robin L | Director | Sep 03 | Exercise / conversion · M | +100,000 | $4.89 | +$489K | 235,000 |
| Smith Robin L | Director | Sep 03 | Exercise / conversion · M | +75,000 | $3.95 | +$296K | 135,000 |
Loading...
